Company: WW
Filing Date: 2025-04-21
Form Type: DEF 14A
Source: 0001193125-25-087213
Chunk: 44

Company: WW INTERNATIONAL, INC.
Filing Date: 2025-04-21
Form: DEF 14A
Chunk 44
---
 expressed as a percentage of base salary, is reviewed by the Compensation Committee periodically. No actions were taken during fiscal 2024 with respect to the annual target bonus percentages of the eligible named executive officers other than the setting of target bonus percentages for Mses. Boyer and Cooke in connection with their commencing employment with the Company. With respect to the fiscal 2024 annual, performance-based cash bonus program, the level of annual cash bonus that could have been earned based on the Company’s financial performance ranged from 0% to 100% of target depending on performance. Following are the target bonus opportunities for the eligible named executive officers approved for the fiscal 2024 annual, performance-based cash bonus program:

| Named Executive Officer |     | Target Bonus Opportunity                     
 (% of Base Salary at Fiscal 2024 Year End or 
 Departure Date, as applicable)               |     |     |   |
|:------------------------|:----|:---------------------------------------------|:----|----:|:--|
| Tara Comonte(1)         |     |                                              |     | N/A |   |
| Donna Boyer             |     |                                              |     | 100 | % |
| Jacqueline Cooke        |     |                                              |     |  60 | % |
| Sima Sistani            |     |                                              |     | 150 | % |
| Heather Stark           |     |                                              |     |  65 | % |

| (1) | Ms. Comonte was not eligible to participate in the Company’s fiscal 2024 annual, performance-based cash bonus program given her interim status. |

29

Company Financial Performance For fiscal 2024, the annual, performance-based cash bonus (the “2024 Bonus Plan”) for each eligible named executive officer was determined using the guidelines and performance criteria generally applicable to all executives of the Company. In April 2024, the Compensation Committee established full-year, operating income as the sole financial performance metric with End of Period Subscribers and Subscription Revenues on both a global and Clinical basis as performance gatekeeper metrics at threshold, as applicable, and for any amount to be paid above target. At such time, the Compensation Committee determined that a rating between 0% and 200% for the portion of each eligible named executive officer’s annual cash bonus determined by the Company’s achievement of its financial performance goals was to be determined based on the following scale:

| Range of Operating Income Financial Performance Goal Ratings |     |                                                                                                                                                                                                                                                       |     |                                                       |
| Percentage of Target Operating